These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 712279)

  • 1. The management of high risk pregnancy.
    Anuman-Rajadhon Y; Pattanachak C; Manassakorn J
    J Med Assoc Thai; 1978 Oct; 61(10):576-85. PubMed ID: 712279
    [No Abstract]   [Full Text] [Related]  

  • 2. Antepartal cardiotocography in the assessment of fetal outcome.
    Käär K
    Acta Obstet Gynecol Scand Suppl; 1980; 94():1-56. PubMed ID: 6935909
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of fetuses in the late pregnancy by serial determinations of serum human placental lactogen levels].
    Kaibara M; Marumoto Y; Taniguchi I; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1724-8. PubMed ID: 7175278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring of HPL, estriol and estetrol in high-risk pregnancy].
    Gherzi R; Pastore M; Labate D
    Minerva Ginecol; 1981 Oct; 33(10):911-6. PubMed ID: 7312213
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of the oxytocin challenge test on levels of maternal serum unconjugated serum estriol and estetrol pre- and post-test in high-risk pregnancies.
    Sampson MB; Kundu N; Peterson LP
    Am J Perinatol; 1986 Jan; 3(1):22-3. PubMed ID: 3942609
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical thinking in modern obstetrics. II. The hormonal and cardiotocographic aspects].
    Katsurov A
    Akush Ginekol (Sofiia); 1985; 24(2):1-8. PubMed ID: 3893188
    [No Abstract]   [Full Text] [Related]  

  • 7. [Importance of the determination of plasma chorionic somatomammotropin in high-risk pregnancy].
    Marsico S; Carbone M; Volpe A; Baviera G
    Arch Ostet Ginecol; 1975; 80(1-3):10-23. PubMed ID: 829748
    [No Abstract]   [Full Text] [Related]  

  • 8. Human placental lactogen.
    Letchworth AT
    Contrib Gynecol Obstet; 1976; 2():114-42. PubMed ID: 802077
    [No Abstract]   [Full Text] [Related]  

  • 9. [At-risk pregnancy (analysis of correlations between parameters)].
    Meriggi E; Sanlorenzo F; Colongo E; Parenti MR; Calleri W
    Ric Clin Lab; 1978; 8 Suppl 2():47-57. PubMed ID: 746301
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interpretation of the fetal heart rate in pregnancy and labor].
    Künzel W; Hohmann M
    Gynakologe; 1984 Dec; 17(4):255-64. PubMed ID: 6519556
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of biochemical tests during pregnancy].
    Takagi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Sep; 36(9):1405-6. PubMed ID: 6491417
    [No Abstract]   [Full Text] [Related]  

  • 12. [Placental lactogen hormone and the oxytocin test. Comparison between 2 diagnostic methods for placental insufficiency].
    Sanchez-Ramos J; Del Olmo J; Botella-Llusia J
    J Gynecol Obstet Biol Reprod (Paris); 1974 Sep; 3(6):895-901. PubMed ID: 4470760
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of composite scoring of biochemical monitoring in fetal distress].
    Zhu FQ
    Zhonghua Fu Chan Ke Za Zhi; 1991 May; 26(3):136-9, 187. PubMed ID: 1874054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine assessment of high-risk pregnancies.
    Petersen LP; Kundu N
    Obstet Gynecol Annu; 1980; 9():169-94. PubMed ID: 6773003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antepartum stress test monitoring.
    Garite TJ; Freeman RK
    Clin Obstet Gynaecol; 1979 Aug; 6(2):295-307. PubMed ID: 498681
    [No Abstract]   [Full Text] [Related]  

  • 16. The uses of oestriol as a monitoring tool.
    Goebelsmann U
    Clin Obstet Gynaecol; 1979 Aug; 6(2):223-44. PubMed ID: 498679
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monitoring of high-risk pregnancies. Complementary aspects of the nonstress test, the oxytocin test and the biophysical score].
    Beco J; Lambotte R
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(8):997-1008. PubMed ID: 3546475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hormonal assessment of fetal and placental function.
    Chard T
    Clin Obstet Gynaecol; 1974 Apr; 1(1):85-102. PubMed ID: 4471499
    [No Abstract]   [Full Text] [Related]  

  • 19. [Development of levels of chorionic somatomommotropic hormone during high risk pregnancies].
    Gaspard U; Franchimont P
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):324-7. PubMed ID: 4681535
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical indications for the purposeful monitoring of at-risk pregnancies using radioimmunological HPL determinations].
    Herter U; Alexander H; Radzuweit H
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():50-6. PubMed ID: 6242694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.